Tag:
Anchor Therapeutics
Latest Headlines
Latest Headlines
Anchor lands $480M discovery pact with J&J unit
Anchor Therapeutics has snared a $480 million preclinical discovery pact with J&J's Ortho-McNeil-Janssen Pharmaceuticals--but it's keeping its upfront payment under wraps. In the deal, which was
Anchor raises $10M, aims for more in Series B
Anchor Therapeutics has raised $10 million in the first close of what the company hopes will be a $30 million Series B round. Current investors TVM Capital, HealthCare Ventures and the Novartis
Renamed Anchor in talks for $30M round, new pact
The fledgling Cambridge, MA-based Ascent Therapeutics is opening up a new chapter in the company's development. It's changing its name, focusing on late-stage discussions for a new licensing pact
